Clinical Research Directory

Inclusion Criteria: * Age subjects 50 and 80 years-old * Ability to express informed consent * Early or moderate dry AMD according to ARDS classification * Overreactive bladder * Visual acuity greater than BCVA 65 EDTRS letters. Exclusion Criteria: * • Any medical condition which contraindicates the use of beta-agonists * Uncontrolled hypertension * Tachycardia or atrial fibrillation * Any allergies to the beta-agonists * Renal or hepatic failure * Long QT or concomitant treatment with drugs that cause lengthening of the QT interval * Any sign of ocular inflammation * xudative AMD * Any ongoing medical or surgical treatment for AMD (including intravitreal injections, oral supplementation of lutein, zeaxanthin and or high dietary intake of antioxidants) * Any other ophthalmic diseases such glaucoma, acute or chronic uveitis, advanced cataract, or any opacities of the ocular media that do not permit high-quality imaging examinations. * Pregnancy * Any condition or disease that in the opinion of the investigators may put the subject at significant risk or may interfere significantly with the subject's participation in the study (i. e. malignancy, uncontrolled or cardiovascular diseases)